- BRSF featured in industry publication as a company that transforms EEG testing in children, cutting procedure time from 30 to as little as 5 minutes.
- The need for brain diagnostics in children is on the rise, but supply and availability of EEG testing to pediatric physicians remains limited.
- BRSF has stepped in to fill the gap in unmet patients’ needs; positioning itself as a leading innovator in this field.
Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, was featured in Med-Tech News, a publication covering medical devices medical manufacturing, as a Company revolutionizing the space of pediatric brain diagnostics (https://ibn.fm/Aslgm). The feature piece authored by Irina Nazarova, marketing director of Brain Scientific, brings to attention the importance of having a new generation of devices for neurological diagnostics in children and why Brain Scientific’s solution is responding to this growing but still largely unmet patient need.
Often left under the radar of technology providers working in neurological diagnostics, the pediatric market also has a need for EEG devices because children can suffer from a number of neurological disorders, including seizures, sleep issues, brain infections and epilepsy. For example, epilepsy as one of the most common neurological disorders in children could lead to dangerous seizures if left undetected. Still, this list of possible pediatric applications of brain diagnostic devices is not exhaustive — it is constantly expanding with new conditions where the novel technology can make a difference for children’s health. For example, EEG testing could also be used for diagnosing ADHD, another growing market need as the article cites Child and Adolescent Psychiatry which reports that children with the disorder make up 42% of all children in the country. It could also be crucial for diagnosing autism, another prevalent condition challenging to diagnose, especially in younger pediatric patients.
Still, despite the apparent unmet need in patient care, the supply and availability of EEG testing to pediatric physicians are limited. That was before Brain Scientific stepped up to the challenge. The article describes how the Company responded with agility to feel the gap and establish a new innovative norm for pediatric clinicians.
After showcasing adult-sized NeuroCap at several medical technology conferences, Brain Scientific was approached by many attendees inquiring if the Company has a pediatric version already available or at least in development. Committed to unveiling emerging market needs and quick to respond to them, Brain Scientific started working to respond to this challenge right away. After plenty of consultations between the Company’s in-house team of specialists and the manufacturers and the medical testers to secure high-quality products, the NeuroCap for children was born — an easy-to-use disposable headset overcoming the infection risk and inconvenience burden of traditional EEG pediatric products.
Nazarova continues explaining that the pediatric version of NeuroCap comes with all the benefits of the adult version. Unlike most EEGs, which require a special technician to conduct the testing with a single machine, one patient at a time, pediatric NeuroCap is a pre-gelled hospital-grade children-size EEG headset that any member of clinical staff can apply. Like the adult edition, the pediatric NeuroCap is quick, disposable, sanitary and comfortable, transforming once tedious process that could take up to 30 minutes per child into a painless and simple routine for medical staff. Illustrating how the pediatric NeuroCap is a game-changer for EEG testing in children, the article reports that this novel device can conduct testing in as little as five minutes, delivering prompt test results. This makes it an excellent fit for pediatric patients in emergency rooms, ICUs, and clinics.
Despite the pandemic-related supply chain challenges, Nazarova concludes that Brain Scientific continues to be committed to help better equip healthcare facilities across the country. NeuroCap for children will join the Company’s proprietary lineup of diagnostic devices to bring affordable, easy-to-use brain diagnostics solutions for children.
For more information, visit the company’s website at www.BrainScientific.com/Invest-Now.
NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
InvestorWire is part of the InvestorBrandNetwork.